LIMK2 Mediates Resistance to Chemotherapeutic Drugs in Neuroblastoma Cells through Regulation of Drug-Induced Cell Cycle Arrest

Grants

Funding Acknowledgements

This project was supported by The Kids' Cancer Project and in part by the Victorian Government's Operational Infrastructure support Program. OB was supported by a Fellowship from the Australian National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.